Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry

Medicine and Dentistry

• Patient 100%
• Systemic Candidiasis 70%
• Amphotericin B 60%
• Infection 50%
• Drug Megadose 20%
• Cytotoxic Agent 20%
• Pyrrole Derivative 20%
• Therapeutic Procedure 20%
• Complication 10%
• Hematologic Malignancy 10%
• Diagnosis 10%
• Group Therapy 10%
• Immunocompromised Patient 10%
• Antifungal Therapy 10%
• Antifungal Agent 10%
• Candidiasis 10%
• Infection in Immunocompromised Patients 10%
• Liver 10%
• Spleen 10%
• Organ 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Chemotherapy 100%
• Invasive Candidiasis 70%
• Amphotericin B 60%
• Infection 50%
• Retrospective Study 40%
• Pyrrole Derivative 20%
• Cytotoxic Agent 20%
• Echinocandin 20%
• Complication 10%
• Hematologic Malignancy 10%
• Candidiasis 10%
• Immunocompromised Patient 10%
• Antifungal Agent 10%